SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-038115
Filing Date
2019-06-19
Accepted
2019-06-19 18:23:01
Documents
2
Period of Report
2019-06-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5603
2 POA DOCUMENT poa.txt EX-24.3_861143 3499
  Complete submission text file 0001209191-19-038115.txt   10475
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Issuer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Abeliovich Asa (Reporting) CIK: 0001778476 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38939 | Film No.: 19907071